ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $132,584,000 | +27812.4% | 1,933 | -84.0% | 0.01% | -75.0% |
| Q3 2014 | $475,000 | +3.5% | 12,083 | -9.4% | 0.04% | 0.0% |
| Q2 2014 | $459,000 | +101.3% | 13,333 | +146.9% | 0.04% | +80.0% |
| Q1 2014 | $228,000 | +4.6% | 5,400 | -5.3% | 0.02% | -4.8% |
| Q3 2013 | $218,000 | – | 5,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |